A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Clinical trial NCT05307939 · RECRUITING

Trial details

NCT number: NCT05307939
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HPV Oropharynx Cancer HPV-Related Carcinoma HPV-Related Malignancy HPV Positive Oropharyngeal Squamous Cell Carcinoma

Start date: 2022-03-24
Primary completion: 2027-03-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.